{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:46:33Z","timestamp":1794541593290,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fuyang Normal University Horizontal Medical Research Special Cultivation Project","award":["No. 2021HXYXZX09"],"award-info":[{"award-number":["No. 2021HXYXZX09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatocellular carcinoma (HCC) is the most common type of malignant liver tumor with poor prognosis. In this study, we investigated the expression of transforming growth factor beta regulator 4 (TBRG4) in HCC and its effects on the proliferation, invasion, and metastasis of HCC cells, and analyzed the possible molecular mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Downloading the expression and clinical information of HCC samples in the TCGA database, analyzing the expression differences of TBRG4 by bioinformatics methods, analyzing the clinical relevance and prognostic significance. Performing GO, KEGG and GSEA enrichment analysis on the TBRG4-related gene set in patient HCC tissues. Applying cell counting, scratch test and Transwell experiment to study the biological function of TBRG4 in HCC. Mitochondrial membrane potential, apoptosis and ROS levels were evaluated to assess cell iron death. Western blot, RT-PCR, laser confocal microscopy and co-immunoprecipitation were used to detect and analyze the downstream signaling pathways and interacting molecules of TBRG4.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Bioinformatics analysis revealed that TBRG4 was abnormally highly expressed in HCC tumor tissues and was associated with poor prognosis and metastasis in HCC patients. GO and KEGG functional enrichment analysis showed that TBRG4 was related to oxidative stress and NADH dehydrogenase (ubiquinone) activity. GSEA enrichment analysis showed that TBRG4 was associated with Beta catenin independent wnt signaling and B cell receptor. Functional experiments confirmed that knocking down TBRG4 could inhibit the proliferation, migration, and invasion of HCC cells. Mechanistically, TBRG4 inhibited the function of HCC cells through the DDX56\/p-AKT\/GSK3\u03b2 signaling pathway. In addition, interference with TBRG4 expression could reduce the mitochondrial membrane potential and accumulate ROS in HCC cells, leading to increased ferroptosis. Co-IP analysis showed that TBRG4 specifically bound to Beclin1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TBRG4 is highly expressed in HCC tumor tissues and is associated with poor prognosis. It may regulate the proliferation, invasion, and metastasis of HCC cells through the DDX56\/p-AKT\/GSK3\u03b2 signaling pathway. TBRG4 may interact with Beclin1 to regulate the ferroptosis of HCC cells.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-11943-1","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T08:02:34Z","timestamp":1707724954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Shanchun","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"issue":"1","key":"11943_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"11943_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"11943_CR3","doi-asserted-by":"publisher","first-page":"21376","DOI":"10.1038\/s41598-020-78545-2","volume":"10","author":"K Liu","year":"2020","unstructured":"Liu K, Huang G, Chang P, et al. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients. Sci Rep. 2020;10(1):21376.","journal-title":"Sci Rep"},{"issue":"12","key":"11943_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683\u201391.","journal-title":"JAMA Oncol"},{"issue":"1","key":"11943_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123\u201333.","journal-title":"Hepatology"},{"issue":"10360","key":"11943_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"15","key":"11943_CR7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med"},{"issue":"3","key":"11943_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/genetics\/147.3.1063","volume":"147","author":"MC Edwards","year":"1997","unstructured":"Edwards MC, Liegeois N, Horecka J, et al. Human CPR (cell cycle progression restoration) genes impart a Far- phenotype on yeast cells. Genetics. 1997;147(3):1063\u201376.","journal-title":"Genetics"},{"issue":"1","key":"11943_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","volume":"532","author":"TS Elton","year":"2013","unstructured":"Elton TS, Selemon H, Elton SM, et al. Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2013;532(1):1\u201312.","journal-title":"Gene"},{"issue":"6b","key":"11943_CR10","first-page":"2561","volume":"13","author":"TE Carey","year":"1993","unstructured":"Carey TE, Van Dyke DL, Worsham MJ. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res. 1993;13(6b):2561\u20137.","journal-title":"Anticancer Res"},{"issue":"3","key":"11943_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/genetics\/132.3.665","volume":"132","author":"H Liu","year":"1992","unstructured":"Liu H, Krizek J, Bretscher A. Construction of a GAL1-regulated yeast cDNA expression library and its application to the identification of genes whose overexpression causes lethality in yeast. Genetics. 1992;132(3):665\u201373.","journal-title":"Genetics"},{"issue":"50","key":"11943_CR12","doi-asserted-by":"publisher","first-page":"25877","DOI":"10.1074\/jbc.M116.730291","volume":"291","author":"E Boehm","year":"2016","unstructured":"Boehm E, Zornoza M, Jourdain AA, et al. Role of FAST Kinase Domains 3 (FASTKD3) in Post-transcriptional Regulation of Mitochondrial Gene Expression. J Biol Chem. 2016;291(50):25877\u201387.","journal-title":"J Biol Chem"},{"key":"11943_CR13","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.2147\/OTT.S249477","volume":"13","author":"F Huang","year":"2020","unstructured":"Huang F, Liao F, Ma G, et al. TBRG4 knockdown suppresses proliferation and growth of human osteosarcoma cell lines MG63 through PI3K\/Akt pathway. Onco Targets Ther. 2020;13:7271\u201381.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"11943_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.14715\/cmb\/2020.66.2.26","volume":"66","author":"J Wang","year":"2020","unstructured":"Wang J, Luo Q, Liu M, et al. TBRG4 silencing promotes progression of squamous cell carcinoma via regulation of CAV-1 expression and ROS formation. Cell Mol Biol (Noisy-le-grand). 2020;66(2):157\u201364.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"4","key":"11943_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/bioinformatics\/btp692","volume":"26","author":"B Li","year":"2010","unstructured":"Li B, Ruotti V, Stewart RM, et al. RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics. 2010;26(4):493\u2013500.","journal-title":"Bioinformatics"},{"issue":"4","key":"11943_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"issue":"1","key":"11943_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12885-022-10099-0","volume":"22","author":"D Cui","year":"2022","unstructured":"Cui D, Cui X, Xu X, et al. Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia. BMC Cancer. 2022;22(1):1027.","journal-title":"BMC Cancer"},{"issue":"14","key":"11943_CR18","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.7150\/thno.72471","volume":"12","author":"H Zhou","year":"2022","unstructured":"Zhou H, Du Y, Wei X, et al. DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling. Theranostics. 2022;12(14):6069\u201387.","journal-title":"Theranostics"},{"key":"11943_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2019.11.029","volume":"470","author":"T Jin","year":"2020","unstructured":"Jin T, Wang C, Tian Y, et al. Mitochondrial metabolic reprogramming: an important player in liver cancer progression. Cancer Lett. 2020;470:197\u2013203.","journal-title":"Cancer Lett"},{"issue":"3","key":"11943_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, et al. Mitochondrial metabolism and cancer. Cell Res. 2018;28(3):265\u201380.","journal-title":"Cell Res"},{"issue":"11","key":"11943_CR21","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3390\/cancers13112571","volume":"13","author":"MI Hern\u00e1ndez-Alvarez","year":"2021","unstructured":"Hern\u00e1ndez-Alvarez MI, Zorzano A. Mitochondrial dynamics and liver cancer. Cancers (Basel). 2021;13(11):2571.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"11943_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/jop.13470","volume":"52","author":"A Ramasubramanian","year":"2023","unstructured":"Ramasubramanian A, Ramani P, Kannan B, et al. High expression of novel biomarker TBRG4 promotes the progression and invasion of oral squamous cell carcinoma. J Oral Pathol Med. 2023;52(8):738\u201345.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"11943_CR23","first-page":"121","volume":"15","author":"A Wang","year":"2018","unstructured":"Wang A, Zhao C, Liu X, et al. Knockdown of TBRG4 affects tumorigenesis in human H1299 lung cancer cells by regulating DDIT3, CAV1 and RRM2. Oncol Lett. 2018;15(1):121\u20138.","journal-title":"Oncol Lett"},{"key":"11943_CR24","doi-asserted-by":"publisher","first-page":"108351","DOI":"10.1016\/j.abb.2020.108351","volume":"686","author":"F Huang","year":"2020","unstructured":"Huang F, Zhou P, Wang Z, et al. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-\u03b21 expression and PI3K\/AKT signaling pathway. Arch Biochem Biophys. 2020;686:108351.","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"11943_CR25","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3390\/biom11111722","volume":"11","author":"A Gutierrez","year":"2021","unstructured":"Gutierrez A, Demond H, Brebi P, et al. Novel methylation biomarkers for colorectal cancer prognosis. Biomolecules. 2021;11(11):1722.","journal-title":"Biomolecules"},{"issue":"6","key":"11943_CR26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/cells10061540","volume":"10","author":"L Zhang","year":"2021","unstructured":"Zhang L, Li X. DEAD-Box RNA helicases in cell cycle control and clinical therapy. Cells. 2021;10(6):1540.","journal-title":"Cells"},{"issue":"34","key":"11943_CR27","doi-asserted-by":"publisher","first-page":"30935","DOI":"10.1074\/jbc.M201919200","volume":"277","author":"M Sharma","year":"2002","unstructured":"Sharma M, Chuang WW, Sun Z. Phosphatidylinositol 3-kinase\/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. J Biol Chem. 2002;277(34):30935\u201341.","journal-title":"J Biol Chem"},{"key":"11943_CR28","doi-asserted-by":"publisher","first-page":"930710","DOI":"10.1155\/2012\/930710","volume":"2012","author":"KM Jacobs","year":"2012","unstructured":"Jacobs KM, Bhave SR, Ferraro DJ, et al. GSK-3\u03b2: a bifunctional role in cell death pathways. Int J Cell Biol. 2012;2012:930710.","journal-title":"Int J Cell Biol"},{"issue":"6","key":"11943_CR29","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s13402-021-00642-9","volume":"44","author":"W Xue","year":"2021","unstructured":"Xue W, Dong B, Zhao Y, et al. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt\/\u03b2-catenin signaling and inhibits apoptosis in cholangiocarcinoma. Cell Oncol (Dordr). 2021;44(6):1351\u201361.","journal-title":"Cell Oncol (Dordr)"},{"issue":"7664","key":"11943_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137.","journal-title":"Nature"},{"issue":"2","key":"11943_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molmed.2020.08.010","volume":"27","author":"M Conrad","year":"2021","unstructured":"Conrad M, Lorenz SM, Proneth B. Targeting ferroptosis: new hope for as-yet-incurable diseases. Trends Mol Med. 2021;27(2):113\u201322.","journal-title":"Trends Mol Med"},{"issue":"7826","key":"11943_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585(7826):603\u20138.","journal-title":"Nature"},{"issue":"5","key":"11943_CR33","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"4","key":"11943_CR34","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/jcp.29232","volume":"235","author":"X Zhang","year":"2020","unstructured":"Zhang X, Sui S, Wang L, et al. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin. J Cell Physiol. 2020;235(4):3425\u201337.","journal-title":"J Cell Physiol"},{"issue":"3","key":"11943_CR35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478(3):1338\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"11943_CR36","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.cell.2019.05.026","volume":"177","author":"L Galluzzi","year":"2019","unstructured":"Galluzzi L, Green DR. Autophagy-independent functions of the autophagy machinery. Cell. 2019;177(7):1682\u201399.","journal-title":"Cell"},{"key":"11943_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","volume":"66","author":"B Zhou","year":"2020","unstructured":"Zhou B, Liu J, Kang R, et al. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89\u2013100.","journal-title":"Semin Cancer Biol"},{"issue":"15","key":"11943_CR38","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","volume":"28","author":"X Song","year":"2018","unstructured":"Song X, Zhu S, Chen P, et al. AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system X(c)(-) activity. Curr Biol. 2018;28(15):2388-2399.e5.","journal-title":"Curr Biol"},{"issue":"4","key":"11943_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41419-022-04764-2","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Huang Y, Mei R, et al. HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT\/GPX4 axis. Cell Death Dis. 2022;13(4):319.","journal-title":"Cell Death Dis"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-11943-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T08:02:41Z","timestamp":1707724961000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-11943-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11943"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-11943-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"11 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committee of the Second Affiliated Hospital of Fuyang Normal University (NO.2023051).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}